Potential use of rapamycin in HIV infection. Marco Donia, James A. McCubrey, Klaus Bendtzen & Ferdinando Nicoletti
|
|
|
- Branden Harrison
- 5 years ago
- Views:
Transcription
1 British Journal of Clinical Pharmacology DOI: /j x Potential use of rapamycin in HIV infection Marco Donia, James A. McCubrey, Klaus Bendtzen & Ferdinando Nicoletti Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review Andrew A. Monte, Ryan Chuang, & Michael Bodmer 932 / Br J Clin Pharmacol / 70:6 / The Authors British Journal of Clinical Pharmacology 2010 The British Pharmacological Society
2 Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction Sharon M. L. Wallace, Kaisa M. Mäki-Petäjä, Joseph Cheriyan, Edward H. Davidson, Lynne Cherry, Carmel M. McEniery, Naveed Sattar, Ian B. Wilkinson & Rajesh K. Kharbanda Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide Anne Flint, Khalil Nazzal, Pawel Jagielski, Charlotte Hindsberger & Milan Zdravkovic Br J Clin Pharmacol / 70:6 / 933
3 Comparison of the agonist-antagonist interaction model and the pool model for the effect of remoxipride on prolactin Guangli Ma, Lena E. Friberg, Gunilla Movin-Osswald & Mats O. Karlsson Lack of clinically relevant drug drug interactions when dalcetrapib is co-administered with ezetimibe Michael Derks, Markus Abt & Mary Phelan 934 / 70:6 / Br J Clin Pharmacol
4 Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients Brian E. Davies, Pau Aceves Baldó, Sian Lennon-Chrimes & Mike Brewster The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation Nuala A. Helsby, Chung-Yee Hui, Michael A. Goldthorpe, Janet K. Coller, May Ching Soh, Peter J. Gow, Janak Z. de Zoysa & Malcolm D. Tingle Br J Clin Pharmacol / 70:6 / 935
5 In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole Landry K. Kamdem, Yong Liu, Vered Stearns, Susan A. Kadlubar, Jacqueline Ramirez, Stacie Jeter, Karineh Shahverdi, Bryan A. Ward, Evan Ogburn, Mark J. Ratain, David A. Flockhart & Zeruesenay Desta Repaglinide-gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism Jinping Gan, Weiqi Chen, Hong Shen, Ling Gao, Yang Hong, Yuan Tian, Wenying Li, Yueping Zhang, Yuwei Tang, Hongjian Zhang, William Griffith Humphreys & A. David Rodrigues 936 / 70:6 / Br J Clin Pharmacol
6 Evaluation of a QT nomogram for risk assessment after antidepressant overdose W. Stephen Waring, Ann Graham, Julie Gray, Allen D. Wilson, Catherine Howell & David N. Bateman Cortisol response to individualised graded insulin infusions: a reproducible biomarker for CNS compounds inhibiting HPA activation Christopher L. H. Chen, Brian A. Willis, Louise Mooney, Guan Koon Ong, Chay Ngee Lim, Stephen L. Lowe, Sitra Tauscher-Wisniewski, Gordon B. Cutler Jr & Stephen D. Wise Br J Clin Pharmacol / 70:6 / 937
7 (R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy Andrea L. Gordon, Olga V. Lopatko, Andrew A. Somogyi, David J. R. Foster & Jason M. White The NK 1 receptor antagonist aprepitant does not alter the pharmacokinetics of high-dose melphalan chemotherapy in patients with multiple myeloma Gerlinde Egerer, Kathrin Eisenlohr, Martina Gronkowski, Juergen Burhenne, Klaus-Dieter Riedel & Gerd Mikus 938 / 70:6 / Br J Clin Pharmacol
Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells
British Journal of Clinical Pharmacology DOI:10.1111/j.1365-2125.2009.03552.x Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells Lindsey Tilling, Philip Chowienczyk & Brian
The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines
The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs
Endogenous Biomarkers for OATP1B: Preclinical to Clinical Translations. Yurong Lai, PhD Drug Metabolism Gilead Sciences
Endogenous Biomarkers for OATP1B: Preclinical to Clinical Translations Yurong Lai, PhD Drug Metabolism Gilead Sciences Outlines Current strategies to assess clinical DDIs for OATP inhibitor Endogenous
CASTLE HOWARD EVENT 2018
Castle Howard Triathlon Saturday 21st July 2018 Castle Howard Triathlon Sunday 22nd July 2018 The 'Brideshead Revisited' Sprint Plus - 800m/46km/8km Includes Macmillan Cancer Support Charity Place Race
BETA 2 -AGONISTS IN ASTHMA TREATMENT
BETA 2 -AGONISTS IN ASTHMA TREATMENT Edited by Romain Pauwels University Hospital Ghent, Belgium Paul M. O'Byrne McMaster University Hamilton, Ontario, Canada :MARCEL DEKKER, INC. NEW YORK BASEL HONG KONG
Increase in syphilis testing and detection of early syphilis among men who have sex with men across Australia
6//26 Increase in syphilis testing and detection of early syphilis among men who have sex with men across Australia 27-24 Eric P.F. Chow,2, Denton Callander 3,4, Christopher K Fairley,2, Lei Zhang,2, Basil
Confronting the Opioid Epidemic: Suboxone in Primary Care
Confronting the Opioid Epidemic: Suboxone in Primary Care Kami Harless, MD 1 The Opioid Epidemic 2 The Opioid Epidemic 3 Washington Epidemic 4 King County Epidemic 5 King County Epidemic 6 Outline Opioid
Cytochrome P450 Drug Interaction Table Flockhart Table
Cytochrome P450 Drug Interaction Table Flockhart Table The table contains lists of drugs in columns under the designation of specific cytochrome P450 isoforms. CYTOCHROME P450 DRUG INTERACTION TABLE A
Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008
Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality
University of Maryland School of Pharmacy Pharmacotherapy Rounds
School of Pharmacy Pharmacotherapy Rounds 2018-2019 Date Time Session Presenter Institution Fri, Sep 28, 2018 12:30-1:30PM Michael Plazak, Mallory Mouradjian, Pressin Our Luck: Pharmacotherapy for Complex
Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.
Working with People Who Use Drugs in HIV Care Settings August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings Facilitator: Liz Hall, CDPH Office of AIDS Matt Curtis,
NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and
Members of The Chinese Medicine Council of Hong Kong, Chinese Medicine Practitioners Board, Chinese Medicines Board and its Committees
Members of The Chinese Medicine Council of Hong Kong, Chinese Medicine Practitioners Board, Chinese Medicines Board and its Committees and of the Chinese Medicine Council of Hong Kong (e) (f) (g) a chairman;
Athletes Posting Team Scotland Consideration Times at Conclusion of Scottish Gas National Open Swimming Championships
Athletes Posting Team Scotland Consideration Times at Conclusion of Scottish Gas National Open Swimming Championships Please note names in italics are nominated athletes pending selection by Team Scotland
Program Schedule Cardiology Update in Sedona: The Heart of the Matter
Thursday, August 3, 2017 Program Schedule Cardiology Update in Sedona: The Heart of the Matter Noon Registration and Exhibits 1:50 p.m. Welcome Announcements SESSION 1 MODERATORS: Luis R. Scott, M.D and
Elizabeth Crawford 1, Shaoxia Yu 2, Lawrence Cohen 2 Justin Gordon 2, Brian Musselman 1, Jing-Tao Wu 2. IonSense, Inc., Saugus, MA
Eliminating Method Development, Sample Preparation and Chromatographic Separations in High-Throughput Bioanalysis Using DART on an Enhanced Resolution Triple-Quadrupole Mass Spectrometer Elizabeth Crawford
PKPD-Modelling of QT Prolongation Following Deliberate Self-Poisonings with Citalopram
PKPD-Modelling of QT Prolongation Following Deliberate Self-Poisonings with Citalopram Lena Friberg 1, Geoffrey Isbister 2, Peter Hackett 3 and Stephen Duffull 1 1 School of Pharmacy, University of Queensland,
ADVANCES IN SKELETAL MUSCLE BIOLOGY IN HEALTH AND DISEASE CONFERENCE PROGRAM
ADVANCES IN SKELETAL MUSCLE BIOLOGY IN HEALTH AND DISEASE CONFERENCE PROGRAM WEDNESDAY, March 6, 2019 Reitz Union, University of Florida 12:15-1:15pm Grant-Writing Workshop, Ground Floor Room G330 12:15-12:45
Descendants of Harold Peter LIBBERTON (1 of 10)
Descendants of Harold Peter (1 of 10) 1042 Harold Peter 31 Mar 1909, Mount Carroll,, Illinois, Died: 08 Mar 1983,,, Missouri, 1146 Eloys Ernestine PESKA 16 Sep 1912, Fulton,, Illinois, Died: 18 Jun 1996,,,
Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients
British Journal of Clinical Pharmacology DOI:1.1111/j.1365-2125.21.378.x Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients Brian E. Davies, 1 Pau Aceves Baldó,
Buprenorphine Access in California
Buprenorphine Access in California James J. Gasper, PharmD, BCPP Pharmacy Benefits Division Department of Health Care Services james.gasper@dhcs.ca.gov Source: CDPH Vital Statisitics Death Statistical
Statement and Return Report for Certification
Statement and Return Report for Certification - State Senator 6th Senatorial District Vote for Page of Assembly District 4 47 6 Total Ballots 54 Total Applicable Ballots 54 96 7 Total Votes 6 Unrecorded
Journal of Chinese Medicine. Vol.20, No.1, Vol.20, No.3,
163 Journal of Chinese Medicine Vol.20, No.1,2 1-96 Vol.20, No.3,4 97-162 ~ - 145 45-135 21 117 79-19 137-135 ~ - 137 65 87-65 - 145-65 - 153-79 - 153-87 47-137 - 65-87 - 47-145 - 145-47 - 19 164 153 HT7
NEW DRUGS. edited by JOHN FEELY MD FRCPI
2 NEW DRUGS edited by JOHN FEELY MD FRCPI Professor of Pharmacology and Therapeutics, Trinity College, and Consultant Physician, St James's Hospital, Dublin Published by the British Medical Journal Tavistock
Team Scotland Aquatics Squad for the Glasgow 2014 Commonwealth Games
Men Scotland Aquatics Squad for the Glasgow 2014 Commonwealth Games Event Nomination Athlete Club Coach Time Posted Times 50m Free 22.58 Richard Schafers 22.47 200m Free 1:48.48 City of Glasgow 1:47.60
FDA s Clinical Drug Interaction Studies Guidance (2017 Draft Guidance)
FDA s Clinical Drug Interaction Studies Guidance (2017 Draft Guidance) Kellie S. Reynolds, Pharm.D. Deputy Director, Division of Clinical Pharmacology IV Office of Clinical Pharmacology (OCP) Office of
Safety profile of Liraglutide: Recent Updates. Mohammadreza Rostamzadeh,M.D.
Safety profile of Liraglutide: Recent Updates Mohammadreza Rostamzadeh,M.D. Pancreatitis: Victoza post-marketing experience: spontaneous reports of pancreatitis For the majority of the cases, there is
Exhibitor Awards for : Winter Fair Division SHEEP, SHEEP SECTION Issued on 06-Dec-2005 at 14:36
Class 61 Exhibitor Awards for :- 2005 Winter Fair Division SHEEP, SHEEP SECTION Issued on 06-Dec-2005 at 14:36 Section, One pair of Welsh Hill Speckled Face 1 D R Lewis Not Supplied 304 2 D R Lewis Not
Cortisol response to individualised graded insulin infusions: a reproducible biomarker for CNS compounds inhibiting HPA activation
British Journal of Clinical Pharmacology DOI:10.1111/j.1365-2125.2010.03781.x Cortisol response to individualised graded insulin infusions: a reproducible biomarker for CNS compounds inhibiting HPA activation
Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care
Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care Mary Jean Christian, MA, MBA, RD, CDE Diabetes Program Coordinator UC Irvine Health Hot Topics: Diabetes
Efficacy and Safety of Seladelpar in Primary Biliary Cholangitis 52-Week Analysis of a Dose-Ranging Phase 2 Study
Efficacy and Safety of Seladelpar in Primary Biliary Cholangitis 52-Week Analysis of a Dose-Ranging Phase 2 Study Bowlus CL, Neff G, Aspinall R, Galambos M, Goel A, Hirschfield G, Kremer AE, Mayo MJ, Swain
OPIOID ADDICTION AND THE BRAIN MICHAEL NERNEY AND ASSOCIATES P.O. BOX 93 LONG LAKE, NY
OPIOID ADDICTION AND THE BRAIN MICHAEL NERNEY AND ASSOCIATES P.O. BOX 93 LONG LAKE, NY 12847-0093 518-624-5351 MCNERNEYLL@FRONTIERNET.NET A DISEASE OF THE BRAIN ASAM Primary chronic disease of the brain
Clinical Policy Title: Pharmocogenetic testing for warfarin (Coumadin ) sensitivity
Clinical Policy Title: Pharmocogenetic testing for warfarin (Coumadin ) sensitivity Clinical Policy Number: 02.01.13 Effective Date: September 1, 2013 Initial Review Date: May 15, 2013 Most Recent Review
Brian Feng Johannes Hermann. NIH Sarah Boyce Andrea McReynolds Patsy Babbitt/S. Brown Kristin Coan Niu Huang Mike Keiser Jerome Hert
Brian Feng Johannes Hermann Bryan Roth Alan Graves Yu Chen Paul Ensberger NIH Veena Thomas Kerim Babaoglu Frank Raushel Sarah Boyce Andrea McReynolds Patsy Babbitt/S. Brown Kristin Coan Niu Huang Mike
Oseltamivir-Warfarin Interaction in Hypoplastic Left Heart Syndrome: Case Report and Review
Oseltamivir-Warfarin Interaction in Hypoplastic Left Heart Syndrome: Case Report and Review Jonathan Wagner, DO a,b,c, Susan M. Abdel-Rahman, PharmD b,c An 8-year-old boy with hypoplastic left heart syndrome
06/28/2012 CIRCUIT COURT FOR CECIL COUNTY DOCKET REPORT
DOCKET REPORT Page No: 1 Friday 29-Jun-2012 Courtroom 1-2nd Floor VMW 08:30AM K-12-000931 State of Maryland vs Stephanie Summerhill Birney Arraignment/Initial Appearance 1 of 1 Rollins 08:30AM K-12-000932
Low grade inflammation and cardiovascular disease
Low grade inflammation and cardiovascular disease Konstantinos Aznaouridis, MD PhD 1 st Department of Cardiology Hippokration Hospital Athens Medical School Atherosclerosis Start from very young To Old
HIV & Women: Neurological Issues
HIV & Women: Neurological Issues Scott Letendre, M.D. Professor of Medicine University of California, San Diego 1 Do women differ from men in their risk for neurocognitive and mood disorders? 2 As the
Optimizing Opioid Dependence Treatment A Guideline for Pharmacists
Optimizing Opioid Dependence Treatment A Guideline for Pharmacists Module 3: Optimal Use of Methadone F e b r u a r y 2 0 1 5 Learning Objectives To know and understand the pathophysiology of substance
Stony Brook University Hospital, Stony Brook, NY 2. TaiGen Biotechnology Co., Ltd, Taipei, Taiwan
A Phase 2, Open-label Study to Evaluate the Safety and Hematopoietic Stem Cell Mobilization of TG- 0054 (burixafor) Alone or in Combination with G- CSF in Patients with Multiple Myeloma, Non- Hodgkin s
THE ART OF DRUG SYNTHESIS
THE ART OF DRUG SYNTHESIS Edited by Douglas S. Johnson Jie Jack Li Pfizer Global Research and Development WILEY-INTERSCIENCE A JOHN WILEY & SONS, INC., PUBLICATION Foreword Preface Contributors xi xiii
Harvard University Affiliated Abstract Presentations at CROI
BOSTON, MASSACHUSETTS February 22 25, 2016 Harvard University Affiliated Abstract Presentations at CROI This table represents abstracts reported to the Harvard University Center for AIDS Research by members
Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
British Journal of Clinical Pharmacology DOI:10.1111/j.1365-2125.2009.03534.x Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Medical Technologies Advisory Committee (MTAC) 72 nd MTAC Meeting Friday 22 nd September 2017 Level1A City Tower, Piccadilly Plaza, Manchester M1 4BT Committee
Methadone Maintenance
Methadone Maintenance A Practical Guide to Pharmacotherapy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Ron Joe, MD, DABAM Objectives I. Pharmacology Of Methadone II. Practical Application of Pharmacology
Optimizing Suboxone in Opioid Addicts
Optimizing Suboxone in Opioid Addicts David Chim, D.O. Integrated Substance Abuse Programs Dept. of Psychiatry, UCLA K30 Translational Research Interest March 24, 2009 dchim@mednet.ucla.edu www.uclaisap.org
Chin-Hui Yang, M.D. Hui-Rong Liu, Sung-Yin Chen, Yen-Fang Huang, Shih-Yan Yang Third Division, Centers for Disease Control, Department of Health,
Comparison of ff Factors affecting the mortality rate of Injecting Drug Users with HIV infection in Taiwan Chin-Hui Yang, M.D. Hui-Rong Liu, Sung-Yin Chen, Yen-Fang Huang, Shih-Yan Yang Third Division,
Substitution Therapy for Opioid Use Disorder The Role of Suboxone
Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM
Poster O_16. Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA; 2. Lifetree Clinical Research, Salt Lake City, UT, USA
Poster O_16 Lack of PK Interaction Between the HCV Protease Inhibitor MK-5172 and Methadone and Buprenorphine/Naloxone in Subjects on Stable Opiate Maintenance Therapy Iain Fraser, 1 Wendy W. Yeh, 1 Christina
Serotonergic mechanisms of MDMA self-administration. Susan Schenk Victoria University of Wellington School of Psychology
Serotonergic mechanisms of MDMA self-administration Susan Schenk Victoria University of Wellington School of Psychology My lab works in the broad area of Behavioural Pharmacology We test the effects of
We model excellence highlights in the 96 th American Association for Thoracic Surgery Annual Meeting
News We model excellence highlights in the 96 th American Association for Thoracic Surgery Annual Meeting Skylar Gao Editorial Office of Journal of Visualized Surgery, Guangzhou 510220, China Correspondence
Descendants of Peter Amman
Descendants of Peter Amman Prepared by: Thomas N. Oatney Table of Contents Descendants of Peter Amman First Generation Second Generation Third Generation Fourth Generation Name Index 2 3 5 First Generation.
CONFIRMATION DOCKET REPORT- 4/4/2019 RONALD B. KING
1950215 BUTTLES MONTOYA, CYNTHIA 1853063 CAIN EDWARDS, KURT W. & REBECCA 1950206 CAIN MACKEY, MICHAEL & REINA, MACKEY 1950209 CAIN MENDEZ, MARICELA RODARTE 1852885 CAIN PAEZ, DANIEL R. 3/25/19 san_report_mattercalendardocket
CONTENTS. Disclosure of Conflict of Interest. None. Is opioid effective in long-term use? Can opioid exacerbate pain? Why are we still using opioids?
Why Are We Still Using Opioids If Opioid Therapy Are So Problematic? Jianren Mao, MD, PhD Richard J. Kitz Professor of Anesthesia Research Harvard Medical School, Harvard University Vice Chair for Research
PACKAGE INSERT TEMPLATE FOR PARACETAMOL SUPPOSITORIES
PACKAGE INSERT TEMPLATE FOR PARACETAMOL SUPPOSITORIES Brand or Product Name [Product name] Suppositories mg Name and Strength of Active Substance(s) Eg Paracetamol 500mg Paracetamol 250mg Paracetamol 125mg
1. Medication cost for patients retained on treatment. 2. Sawubona program subscription, including support and SMS fees.
Cost Benefit Analysis 10 April 2013 Introduction Sawubona aims to use automated SMS to improve HIV treatment outcomes in a sustainable manner. To do this, we must demonstrate a positive net benefit. The
Genetics and Genomics: Influence on Individualization of Medication Regimes
Genetics and Genomics: Influence on Individualization of Medication Regimes Joseph S Bertino Jr., Pharm.D., FCCP Schenectady, NY USA Goals and Objectives To discuss pharmacogenetics and pharmacogenomics
Models of good practice in drug treatment in Europe. Project group
Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008
What Do You Mean The Morphine Isn t Working? Objectives. Opioid Epidemic. Ellen Fulp, PharmD, BCGP Clinical Education Coordinator AvaCare, Inc.
What Do You Mean The Morphine Isn t Working? Ellen Fulp, PharmD, BCGP Clinical Education Coordinator AvaCare, Inc. 42 nd Annual Hospice & Palliative Care Conference September 2018 Charlotte, NC Objectives
4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING
Opioid Use Disorder in Pregnancy 2017 Recommendations from ACOG and The Pew Charitable Trust KATHY D. HARTKE, MD, LEGISLATIVE CO-CHAIR AND IMMEDIATE PAST CHAIR, WISCONSIN SECTION OF THE AMERICAN COLLEGE
ARVO Annual Meeting, May 1, 2018, Honolulu, Hawaii
ARVO Annual Meeting, May 1, 2018, Honolulu, Hawaii A novel oral plasma kallikrein (PKal) inhibitor KV123833 blocks VEGF-mediated retinal vascular hyperpermeability in a murine model of retinal edema (#3464)
Program Schedule Cardiology Update: The Heart of the Matter 2018
Program Schedule Cardiology Update: The Heart of the Matter 2018 Thursday, August 2, 2018 12:00 p.m. Registration and Exhibits 1:50 p.m. Welcome Announcements SESSION 1 2:00 p.m. Syncope in Patients with
Statement and Return Report for Certification
Statement and Return Report for Certification General Election 3 - /5/3 - Member of the City Council st Council District Vote for Page of 8 /3/3 :3:8PM Assembly District 65 General Election 3 - /5/3 Member
Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC
Medications for Opioid Use Disorder Charles Brackett, MD, MPH General Internal Medicine, DHMC Opioid Related Deaths are on the Rise in the US National Vital Statistics System Mortality File Deaths are
Guidelines for performing gynaecological endoscopic procedures
Guidelines for performing gynaecological endoscopic procedures This statement has been developed by the Women s Health Committee. It has been reviewed by the Endoscopic Surgery Advisory Committee (RANZCOG/AGES)
33rd District Court of Blanco County Honorable J. Allan Garrett Family/Civil 9:00 a.m. 04/22/2016
33rd District Court of Blanco County Honorable J. Allan Garrett Family/Civil 9:00 a.m. 04/22/2016 Cause Number Case Style Plaintiff Attorney Defendant Attorney Final Hearing - Uncontested B8013 9:00 AM
Management of chronic pre-existing or treatment-emergent adverse events of the other systemic therapies. Michael J. Morris, MD
Management of chronic pre-existing or treatment-emergent adverse events of the other systemic therapies Michael J. Morris, MD www.mskcc.org Disclosures Research funding (institutional contracts): Sanofi
Evaluation of Drug-Drug Interactions FDA Perspective
Evaluation of Drug-Drug Interactions FDA Perspective Kellie Schoolar Reynolds, Pharm.D. Deputy Director Division of Clinical Pharmacology IV Office of Clinical Pharmacology Office of Translational Sciences
Falk Symposium 156: Genetics in Liver Disease. Pharmacogenetics. Gerd Kullak-Ublick
Falk Symposium 156: Genetics in Liver Disease Pharmacogenetics Gerd Kullak-Ublick Division of Clinical Pharmacology and Toxicology Department of Internal Medicine University Hospital Zurich Freiburg, 8.
Drug Review Rozerem (ramelteon)
Drug Review Rozerem (ramelteon) Introduction 1 Ramelteon is a melatonin receptor agonist with affinity for MT 1 and MT 2 and selectivity over the MT 3 receptor. The activity at the MT 1 and MT 2 receptors
Fibrinogen does not relate to cardiovascular or muscle manifestations in chronic
Fibrinogen does not relate to cardiovascular or muscle manifestations in chronic obstructive pulmonary disease (COPD): cross-sectional data from the ERICA study Divya Mohan 1,2*, Julia R Forman 3, Matthew
Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Gene(s)/Level of evidence
Drug Gene(s)/Level of evidence Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Haloperidol CYP2D6 ( SLC6A5 ( 2D6: DPWG guidelines Reduce dose by 50% in PMs Aripiprazole
CHRONIC PAIN MANAGEMENT
CHRONIC PAIN MANAGEMENT Betty J Harris, PharmD. 2014 Objectives Explain the consequences of untreated pain. Identify common causes of chronic non-malignant pain in adults. Identify steps to assessing pain,
Merja Kokki MD, PhD Department of Anaesthesiology and Intensive Care, Kuopio University Hospital, School of Medicine, University of Eastern Finland
Long-acting opioids in obstetric analgesia and the newborn Merja Kokki MD, PhD Department of Anaesthesiology and Intensive Care, Kuopio University Hospital, School of Medicine, University of Eastern Finland
Mortality Reduction Associated With β-adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes
1/5 Mortality Reduction Associated With β-adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes Klaus K. Witte, Michael Drozd, Andrew M.N. Walker, Peysh A. Patel, Jessica
It s Not Just One More Thing! Overcoming Obstacles for Buprenorphine Treatment by Residents, Faculty and Programs
It s Not Just One More Thing! Overcoming Obstacles for Buprenorphine Treatment by Residents, Faculty and Programs Ken Saffier, MD Maureen Strohm, MD May 7, 2017 Disclosures Ken Saffier, MD, has nothing
Opioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine
Opioid Use Disorders and Pregnancy Marcela Smid, MD Maternal-Fetal Medicine UNIVERSITY OF UTAH HEALTH, 2017 OBJECTIVES Definitions Epidemiology Pharmacology Effects on pregnancy Screening Treatment CARE
APA Handbook of Behavior Analysis
APA Handbooks in Psychology APA Handbook of Behavior Analysis VOLUME 1 Methods and Principles Gregory J. Madden, Editor-in-Chief William V. Dube, Timothy D. Hackenberg, Gregory P. Hanley, and Kennon A.
February 2019 Grand Jury
Name Hometown DOB Charges 1 Arbaugh, James Matthew Ronceverte, WV 10/6/1979 Possession With Intent to Deliver a Controlled 2 Arbaugh, James Matthew Ronceverte, WV 10/6/1979 Delivery of a Controlled Substance
Treatment of Opioid Use Disorder During Pregnancy
Treatment of Opioid Use Disorder During Pregnancy Cheyenne Johnson RN, MPH, CCRP Director Clinical Activities and Development, British Columbia Center on Substance use Disclosure No conflict of interest
Quality & Patient Safety Innovation Summit, May 22-24, 2013 Evaluation Form
Quality & Patient Safety Innovation Summit, May -, 0 Evaluation Form Please print form, complete and return via email to lisa@jamiebelkin.com or fax to 6.9.0.. Please tell us about yourself. Position:
Progesterone support of the luteal phase and in the first trimester
Progesterone support of the luteal phase and in the first trimester This statement has been developed and reviewed by the Women s Health Committee and approved by the RANZCOG Board and Council. A list
VARUBI (rolapitant) tablets, for oral use VARUBI (rolapitant) injectable emulsion, for intravenous use Initial U.S. Approval: 2015
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VARUBI safely and effectively. See full prescribing information for VARUBI. VARUBI (rolapitant) tablets,
Drug - Natural Product Interactions- Labeling Implications
AAPS, PPDM November 10, 2005 Nashville, TN Drug - Natural Product Interactions- Labeling Implications Shiew-Mei Huang, Ph.D. Deputy Director for Science Office of Clinical Pharmacology & Biopharmaceutics
Poisoning: from paracetamol to legal highs.
Poisoning: from paracetamol to legal highs. or Something old, something new, something borrowed, something blue. Nick Bateman University of Edinburgh Question 1 Which of the following agents was associated
Scottish Health Protection Update
09:15-09:45 Registration & Coffee CALEDONIAN LOUNGE (Ground Floor) CALEDONIAN SUITE (Ground Floor) 09:45-10:00 Welcome and Introduction Professor Mahmood Adil Medical Director NHS National Services Scotland
RFM: Janice Chua (Mrs) FM: Yong Tze Woon (mr) FM: Thong Yoke Lian (Mrs) FM: Shaikhah (Ms)
Sec 4 s (Y2017) Sec 4E1 AM BI BI (Lab) Bi (SPA) CH CH (Lab) RFM: Janice Chua (Mrs) FM: Yong Tze Woon (mr) FM: Thong Yoke Lian (Mrs) FM: Shaikhah (Ms) Yeo Ling Seem (Ms) Tan-Wong Woei Ling (Mrs) Koo Ching
PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN ELDERLY CANCER PATIENTS JØRN HERRSTEDT, M.D. COPENHAGEN UNIVERSITY HOSPITAL HERLEV, DENMARK
PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN ELDERLY CANCER PATIENTS JØRN HERRSTEDT, M.D. COPENHAGEN UNIVERSITY HOSPITAL HERLEV, DENMARK HISTORY OF ANTIEMETICS 1979 A corticosteroid is superior
Quetiapine Case 1 Warfarin Jose de Leon, MD
Quetiapine Case 1 Warfarin 1-23-16 Jose de Leon, MD 1. Quetiapine Case 1 J Clin Psychopharm 1999;19:382-3 http://www.ncbi.nlm.nih.gov/pubmed/10440472 Educational Objectives At the conclusion of this presentation,
comprehensive pharmacy review
3rd edition comprehensive pharmacy review EDITORS, Ph.D., R.Ph., Pharm.D., R.Ph. Paul F. Souney, M.S., R.Ph., Pharm.D., R.Ph. Lawrence H. Block, Ph.D., R.Ph. Williams &: Wilkins A WAVERLY COMPANY BALTIMORE
SUBSTANCE ABUSE AND DEPENDENCE
SUBSTANCE ABUSE AND DEPENDENCE Substance Abuse and Dependence An Introduction for the Caring Professions Edited by HAMID GHODSE DOUGLAS MAXWELL St George's Hospital and Medical School, London PETROLEUM
Please note: ASD Healthcare will continue to support and provide distribution for Varubi Oral tablets.
Customer Service P 800.746.6273 F 800.547.9413 M-Th 7:00a.m.-6:30p.m. (CST) F 7:00a.m.-6:00p.m. (CST) www.asdhealthcare.com Varubi IV Distribution Suspension March 14, 2018 Tesaro elects to suspend distribution
The Opioid-Exposed Woman
The Opioid-Exposed Woman Management Considerations for Labor and Delivery Jane Sublette, MS, RN, CNM, WHNP-BC Fairview Ridges Hospital Objectives Describe opioid-associated risks to the mother and fetus
REVEAL: Randomized placebo-controlled trial of anacetrapib in 30,449 patients with atherosclerotic vascular disease
REVEAL: Randomized placebo-controlled trial of anacetrapib in 30,449 patients with atherosclerotic vascular disease Martin Landray and Louise Bowman on behalf of the HPS 3 / TIMI 55 - REVEAL Collaborative
PREDICTING PHARMACOKINETICS FOLLOWING TOPICAL APPLICATION USING NON-ANIMAL METHODS IAN SORRELL, MI-YOUNG LEE, RICHARD CUBBERLEY
PREDICTING PHARMACOKINETICS FOLLOWING TOPICAL APPLICATION USING NON-ANIMAL METHODS IAN SORRELL, MI-YOUNG LEE, RICHARD CUBBERLEY UNILEVER APPLICATIONS KINETICS Need for estimates of local and systemic concentrations
Prescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D
Prescription Pain Management University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D 2 Objectives Understand how to preform a pain assessment Know which medications
Mandarin Translations
British Journal of Pharmacology DOI:0./j.476-538.202.0247.x www.brjpharmacol.org To cite any of the articles below, please refer to the full article and not the DOI of this translations section. b 2 -adrenoceptor
Antihyperlipidemic Drugs
Antihyperlipidemic Drugs Lipid disorders: Disorders of lipid metabolism are manifest by elevation of the plasma concentrations of the various lipid and lipoprotein fractions (total and LDL cholesterol,